Zeltiq Aesthetics Inc 4
4 · Zeltiq Aesthetics Inc · Filed Jun 19, 2013
Insider Transaction Report
Form 4
Tatsutani Kristine N
CTO and VP
Transactions
- Sale
Common Stock
2013-06-14$5.80/sh−14,127$81,937→ 30,769 total - Exercise/Conversion
Stock Option (Right to buy)
2013-06-14−14,127→ 68,183 totalExercise: $2.83Exp: 2021-05-17→ Common Stock (14,127 underlying) - Exercise/Conversion
Stock Option (Right to buy)
2012-06-17−4,413→ 63,770 totalExercise: $2.83Exp: 2021-05-17→ Common Stock (4,413 underlying) - Exercise/Conversion
Common Stock
2013-06-14$2.83/sh+14,127$39,923→ 44,896 total - Exercise/Conversion
Common Stock
2013-06-14$2.83/sh+4,413$12,471→ 35,182 total - Sale
Common Stock
2013-04-23$5.80/sh−4,413$25,595→ 30,769 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 13, 2012
- [F2]25% of the granted 117,696 shares became exercisable on 5/18/2012. The remaining vest in a series of 36 equal monthly installments; provided the Reporting Person continues to provide service to ZELTIQ Aesthetics, Inc.